Kinetic Analysis of Molecular Interconversion of Immunosuppressant FK506 by High-Performance Liquid Chromatography
- 1 January 1993
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 10 (12) , 1785-1789
- https://doi.org/10.1023/a:1018938618032
Abstract
High-performance liquid chromatography of FK506, a macrolide immunosuppressant, was performed on a reversed-phase column. The peak was broad with the column kept at room temperature, which was accounted for by slow interconversion between the two forms of FK506. With the use of a heated column, a sharp peak was observed because of the rapid interconversion at high temperature. When the column was cooled to 0°C, two sharp peaks were observed because essentially no interconversion occurred at 0°C during elution. Analysis of the chromatograms obtained at various eluant flow rates indicated that the conversion of the two forms follows first-order kinetics, and the apparent activation energies for the conversions were calculated. The interconvertibility between two molecular forms may be related to the immunosuppressive activity.Keywords
This publication has 9 references indexed in Scilit:
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant ComplexScience, 1991
- Inhibition of FKBP Rotamase Activity by Immunosuppressant FK506: Twisted Amide SurrogateScience, 1990
- Pharmacokinetics of FK 506: preclinical and clinical studies.1990
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring.Clinical Chemistry, 1989
- Optimizing cyclosporine therapy: dose, levels, and monitoring.1988
- Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.The Journal of Immunology, 1987